Sale Of Lupus Drug License Option To Cephalon Sets Up Immupharma Business Strategy
This article was originally published in The Pink Sheet Daily
Executive Summary
U.K. biotech says partnership with French research institution, recent cash infusions leave it well-funded.
You may also be interested in...
Deals Of The Week: Wyeth/Santaris, Novartis/HHS, Cephalon/Ception ...
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
Deals Of The Week: Wyeth/Santaris, Novartis/HHS, Cephalon/Ception ...
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
Cephalon Option To Buy Biologics Firm Ception Gets The Ball Rolling For 2009, CEO Says
Look for Cephalon to “roll up” more assets this year while the market is good, CEO Baldino says at J.P. Morgan.